- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 239/46 - Two or more oxygen, sulfur or nitrogen atoms
Patent holdings for IPC class C07D 239/46
Total number of patents in this class: 112
10-year publication summary
|
5
|
7
|
4
|
4
|
6
|
3
|
1
|
2
|
1
|
1
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Takeda Pharmaceutical Company Limited | 2728 |
4 |
| Gilead Sciences, Inc. | 2167 |
4 |
| Vertex Pharmaceuticals Incorporated | 1604 |
3 |
| ADAMA Makhteshim Ltd. | 539 |
3 |
| Emory University | 1692 |
3 |
| Lek Pharmaceuticals d.d. | 192 |
3 |
| Memorial Sloan-Kettering Cancer Center | 2007 |
3 |
| Acea Therapeutics, Inc. | 29 |
3 |
| F. Hoffmann-La Roche AG | 7861 |
2 |
| The Regents of the University of California | 20494 |
2 |
| Boehringer Ingelheim International GmbH | 4569 |
2 |
| British Columbia Cancer Agency Branch | 185 |
2 |
| Eli Lilly and Company | 4007 |
2 |
| Flamma S.p.A. | 18 |
2 |
| Janssen Sciences Ireland UC | 171 |
2 |
| Purdue Pharmaceutical Products L.P. | 31 |
2 |
| Shionogi & Co., Ltd. | 834 |
2 |
| Socpra Sciences et Genie S.E.C. | 207 |
2 |
| Taisho Pharmaceutical Co., Ltd. | 862 |
2 |
| Versitech Limited | 371 |
2 |
| Other owners | 62 |